Welcome : Guest

Biosimulation Trends

Abstract

Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development.

The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.

Code: 146055
Price: $950
Companies : 36
Pages: 11
Date: January, 2014
Market Data Tables : 1

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
A Prelude......1
Table 1: Global Biosimulation Market (2012-2017) in US$ Million......1
Biosimulation - Revolutionizing Drug Discovery......2
Biosimulation - Models......2
Biosimulation Software......2
Accelrys Introduces Discovery Studio 3.5......3
Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases......3
Rhenovia Pharma Sets Up International Subsidiary in the US......3
Rhenovia Pharma Inks an Agreement with Portmann......4
Entelos and RegeneMed Introduce iToxFX Service......4
Accelrys, Inc. (USA)......5
Advanced Chemistry Development, Inc. (Canada)......5
Anoixis Corporation (USA)......5
Aptiv Solutions (USA)......5
Archimedes, Inc. (USA)......5
Certara LP (USA)......6
Chemical Computing Group, Inc. (Canada)......6
Cognigen Corporation (USA)......6
Compugen Ltd. (Israel)......6
Entelos, Inc. (USA)......6
Genedata AG (Switzerland)......7
GNS Healthcare (USA)......7
Immunetrics, Inc. (USA)......7
In Silico Biosciences, Inc. (USA)......7
InhibOx Ltd. (UK)......7
INOSIM Software GmbH (Germany)......8
Insilico Biotechnology AG (Germany)......8
Kinetigen, Inc. (USA)......8
LeadInvent (India)......8
Leadscope, Inc. (USA)......8
Molecular Knowledge Systems, Inc. (USA)......8
Nimbus Discovery LLC (USA)......9
Novo Nordisk A/S (Denmark)......9
Open Eye Scientific Software, Inc. (USA)......9
Optimata Ltd. (Israel)......9
PhinC Development (France)......9
Physiomics PLC (UK)......9
Rhenovia Pharma SAS (France)......10
Rosa & Company LLC (USA)......10
Schrodinger LLC (USA)......10
Simcyp Ltd. (UK)......10
Simulations Plus, Inc. (USA)......10
Synergix Ltd. (Israel)......11
Tessella Ltd. (UK)......11
TheraSim (USA)......11
VirtuCel, Inc. (USA)......11